Vident Advisory’s Aehr Test Systems AEHR Stock Holding History

Vident Advisory’s Portfolio AEHR Stock Details AEHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$495K	Sell	5,158 -2,150	-29%	-$196K	﹤0.01%	1370
2026 Q1	$271K	Buy	+7,308	New	+$234K	﹤0.01%	1559

Other funds holding AEHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vident Advisory's AEHR Position: Q2 2026 in Review

Vident Advisory reduced its Aehr Test Systems (AEHR) stake by 29% in Q2 2026, selling an estimated $196K and leaving 5,158 shares worth $495K. The position accounts for ﹤0.01% of the portfolio, ranked #1370.

Vident Advisory first reported a position in AEHR in Q1 2026 and has held it in 2 quarters since. 262 funds tracked by Wall St. Rank hold AEHR as of Q2 2026.

Vident Advisory held 5,158 shares of Aehr Test Systems worth $495K as of Q2 2026.
Vident Advisory sold 2,150 Aehr Test Systems shares in Q2 2026, an estimated $196K.
Aehr Test Systems made up ﹤0.01% of Vident Advisory's portfolio in Q2 2026, its #1370 holding.
Vident Advisory first reported a position in Aehr Test Systems in Q1 2026 and has held it in 2 quarters since.
262 funds tracked by Wall St. Rank held Aehr Test Systems as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.